Results 171 to 180 of about 71,079 (262)
ABSTRACT Background Drug‐induced hyperpigmentation accounts for 10%–20% of acquired pigmentary disorders and can be misdiagnosed for other causes such as melasma, post inflammatory changes, or heavy metal deposition. Kratom (Mitragyna speciosa), a Southeast Asian plant with an opioid‐like profile, has been increasingly used in the United States for ...
Rita Kamoua +4 more
wiley +1 more source
Trends in antipsychotic drug utilisation and indication in the paediatric population: a nationwide cohort study in Sweden. [PDF]
S Kamgang KH +4 more
europepmc +1 more source
ABSTRACT Background Lifestyle interventions targeting metabolic health may influence chronic kidney disease (CKD) risk, particularly among adults with type 2 diabetes and obesity. We evaluated real‐world associations between a telehealth‐delivered, individualized nutrition therapy program (VINT) and CKD incidence and progression compared with usual ...
Shaminie J. Athinarayanan +7 more
wiley +1 more source
Trends in the Use of Atypical Antipsychotics Among Children and Adolescents With Bipolar Spectrum Disorders in Korea. [PDF]
Park KJ, Kim YJ, Jung E, Kim JY, Kim HW.
europepmc +1 more source
ABSTRACT Aims Financial constraints often limit healthy eating among individuals with Type 2 diabetes (T2D) and lower socioeconomic status (SES). Produce Prescription Programs (PRx), which provide financial support for healthy foods, have shown promise in the United States but remain understudied in Europe.
Carmen A. W. Dietvorst +5 more
wiley +1 more source
Documented Borderline Personality Disorder and EMR Indicators of Potential Under-Recognition in Depressive Outpatients. [PDF]
Dang L +6 more
europepmc +1 more source
ABSTRACT Aims To evaluate whether a community‐based personalised lifestyle intervention guided by intermittent continuous glucose monitoring (CGM) improves glycaemic and cardiometabolic outcomes in adults with type 2 diabetes. Materials and Methods In this multicentre, open‐label randomised trial, 180 adults with type 2 diabetes and pre‐randomisation ...
Yaqing Liu +6 more
wiley +1 more source
We investigated the potential of iloperidone as an activator of Sigma‐1 receptor (S1R) neuroprotective function in juvenile Huntington's disease (jHD). We tested iloperidone on cortical neurons differentiated from patient‐derived iPSCs, demonstrating that it acts as a S1R agonist, decreasing apoptosis, huntingtin aggregation, and oxidative stress ...
Ersilia Fornetti +11 more
wiley +1 more source

